Viatris Inc. Common Stock (VTRS)

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
$0.20 (-1.52%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0

About

Business overview of Viatris Inc. Common Stock (VTRS)
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Key Insights

Critical company metrics and information
  • Share Price

    $12.95
  • Market Cap

    $15.45 Billion
  • Total Outstanding Shares

    1.19 Billion Shares
  • Total Employees

    38,000
  • Dividend

    $0.12 Per Share Quarterly
  • IPO Date

    April 14, 1986
  • SIC Description

    Pharmaceutical Preparations
  • Homepage

    https://www.viatris.com

Historical Stock Splits

Execution DateSplit Amount
No Historical Stock Splits

Cash Flow Statement

July 1, 2024 to September 30, 2024
MetricValue
Net Cash Flow, Continuing$937.70 Million
Net Cash Flow From Investing Activities, Continuing$1.75 Billion
Net Cash Flow From Financing Activities, Continuing$-1.64 Billion
Net Cash Flow From Investing Activities$1.75 Billion
Net Cash Flow From Operating Activities$826.50 Million
Net Cash Flow From Financing Activities$-1.64 Billion
Net Cash Flow$961.60 Million
Net Cash Flow From Operating Activities, Continuing$826.50 Million
Exchange Gains/Losses$23.90 Million

Income Statement

July 1, 2024 to September 30, 2024
MetricValue
Diluted Earnings Per Share$0.08
Operating Expenses$1.23 Billion
Benefits Costs and Expenses$3.66 Billion
Income Tax Expense/Benefit$-4.30 Million
Operating Income/Loss$225.90 Million
Income/Loss From Continuing Operations Before Tax$90.50 Million
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic$0.00
Income Tax Expense/Benefit, Deferred$-312.40 Million
Net Income/Loss Available To Common Stockholders, Basic$94.80 Million
Costs And Expenses$3.66 Billion
Preferred Stock Dividends And Other Adjustments$0.00
Cost Of Revenue$2.29 Billion
Revenues$3.75 Billion
Other Operating Expenses$31.50 Million
Interest Expense, Operating$145.60 Million
Net Income/Loss$94.80 Million
Basic Earnings Per Share$0.08
Net Income/Loss Attributable To Noncontrolling Interest$0.00
Research and Development$198.40 Million
Gross Profit$1.46 Billion
Selling, General, and Administrative Expenses$1.00 Billion
Diluted Average Shares$1.20 Billion
Common Stock Dividends$0.12
Net Income/Loss Attributable To Parent$94.80 Million
Basic Average Shares$1.19 Billion
Income/Loss From Continuing Operations After Tax$94.80 Million

Balance Sheet

July 1, 2024 to September 30, 2024
MetricValue
Wages$668.20 Million
Noncurrent Assets$33.45 Billion
Current Assets$11.31 Billion
Liabilities$24.96 Billion
Noncurrent Liabilities$17.45 Billion
Assets$44.75 Billion
Inventory$4.08 Billion
Prepaid Expenses$134.50 Million
Intangible Assets$17.98 Billion
Other Current Liabilities$6.84 Billion
Other Current Assets$4.23 Billion
Liabilities And Equity$44.75 Billion
Current Liabilities$7.51 Billion
Equity Attributable To Parent$19.79 Billion
Accounts Receivable$2.86 Billion
Other Non-current Assets$12.79 Billion
Fixed Assets$2.68 Billion
Equity Attributable To Noncontrolling Interest$0.00
Equity$19.79 Billion

Historical Dividends

Current dividend: $0.12 Per Share Quarterly
Announcement DatePayment DateRecord DateAmountFrequency
Nov 4, 2024Dec 13, 2024Nov 22, 2024$0.12Quarterly
Aug 5, 2024Sep 13, 2024Aug 23, 2024$0.12Quarterly
May 6, 2024Jun 14, 2024May 24, 2024$0.12Quarterly
Feb 26, 2024Mar 18, 2024Mar 11, 2024$0.12Quarterly
Nov 7, 2023Dec 15, 2023Nov 24, 2023$0.12Quarterly
Aug 4, 2023Sep 15, 2023Aug 24, 2023$0.12Quarterly
May 5, 2023Jun 16, 2023May 24, 2023$0.12Quarterly
Feb 24, 2023Mar 17, 2023Mar 9, 2023$0.12Quarterly
Nov 7, 2022Dec 16, 2022Nov 23, 2022$0.12Quarterly
Aug 4, 2022Sep 16, 2022Aug 24, 2022$0.12Quarterly
May 5, 2022Jun 16, 2022May 24, 2022$0.12Quarterly
Jan 6, 2022Mar 16, 2022Feb 24, 2022$0.12Quarterly
Nov 8, 2021Dec 16, 2021Nov 23, 2021$0.11Quarterly
Aug 9, 2021Sep 16, 2021Aug 24, 2021$0.11Quarterly
May 10, 2021Jun 16, 2021May 24, 2021$0.11Quarterly
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.